Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.

Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.

Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.

"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"

Aptar Digital Health and Tasso Combine Capabilities to Facilitate Blood Sample Collection for Multiple Indications Including Chronic Conditions and Oncology

The Tasso blood collection devices will be available to patients included in Aptar Digital Health randomized-clinical trials and real-world studies, as well as to life science companies with whom Aptar Digital Health collaborates to develop digital health solutions, such as digital therapeutics, disease management platforms and digital PSPs.

Dosing Pumps

The Importance Of Dosing Pumps In The Laboratory

Dosing pumps are crucial linchpins in any modern laboratory. They’re mechanical workhorses, ensuring accurate and consistent delivery of various fluids. Their importance is underscored by

Clinical Flow Cytometry

BD Launches New Robotic System to Automate Clinical Flow Cytometry

The BD FACSDuet™ Premium Sample Preparation System leverages liquid-handling robotics to automate the entire sample preparation process, for both in vitro diagnostics (IVD) and user-defined tests, including cocktailing, washing and centrifuging – and then automatically transfers samples to the physically integrated BD FACSLyric™ Clinical Flow Cytometry System, without human interaction. By being integrated with the flow cytometer, the BD FACSDuet™ Premium System enables a “walkaway” workflow solution that requires fewer manual steps, fewer resources and less user hands-on time than previous solutions.

Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future

Ceryx Medical Raises £3.8m In Seed Funding

Funding will be used to commercialize its unique cardiology technology and commence the first-in-human clinical study of the Ceryx Medical innovative cardiac rhythm management device, Cysoni, later this year.

Industry Expert Byline

AI-Integrated Medical Devices

The Rise of AI-Integrated Medical Devices: What’s Changing in 2025 and Beyond

Almost every healthcare system today relies on well-established specialties – cardiology, radiology, endocrinology, and more, to deliver care within clearly defined domains. These expert-driven disciplines, supported by tried-and-true processes and technologies, have long formed the backbone of modern medicine. Clinicians are trained and evaluated based on their deep knowledge and mastery within these areas. And for the most part, this approach works.

Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer

Associate Professor Eunah Kang and Mr. Youngjun Kim from the School of Chemical Engineering and Material Science at Chung-Ang University, Korea have recently come up with an elegant solution. The duo has developed an electrochemical DNA biosensor using a graphitic nano-onion/molybdenum disulfide (MoS2) nanosheet composite, which effectively detects human papillomavirus (HPV)-16 and HPV-18, and can serve as an early diagnosis of cervical cancer.

Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies

“We are delighted to enter into this collaboration with Gustave Roussy, a leading comprehensive cancer center in Europe and worldwide,” said Corinne Danan, general manager of Veracyte’s Biopharma business unit. “This partnership will enable us to augment our Veracyte Biopharma Atlas reference database with a large number of patients tumor samples and data from innovative cancer therapies. Ultimately, we believe this tool may help our biopharmaceutical partners accelerate development of new, precision-medicine therapies that improve outcomes for patients with cancer.”

Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies

FDA Medical Device Updates

Our Experts - Byline Articles

Medical Imaging Technologies and Their Impact on Modern Healthcare

Healing Headlines, Transforming Lives: Hospitals in the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Healthcare - Understanding the Business Side of the Industry and Its Implications

Healthcare Careers and Opportunities in the Evolving Medical Field

Nurses Corner: A Dedicated Space for Professional Insights and Resources

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.